Prince Pharmaceutical Co (ROCO:6935) Change In Inventory: NT$-126 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6935 Prince Pharmaceutical Co Ltd ROCO:6935
62 GF Score
Price NT$27.10
GF Value NT$42.29
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Prince Pharmaceutical Co Change In Inventory?

Prince Pharmaceutical Co ROCO:6935 -8.75% 62 Change In Inventory is NT$-126 Mil as of Jun. 2026. GuruFocus rates ROCO:6935 with a GF Score™ of 62/100 and a GF Value™ of NT$42.29 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Prince Pharmaceutical Co's change in inventory for the quarter that ended in Jun. 2026 was NT$-94 Mil. It means Prince Pharmaceutical Co's inventory increased by NT$94 Mil from Dec. 2025 to Jun. 2026 .

Prince Pharmaceutical Co's change in inventory for the fiscal year that ended in Dec. 2025 was NT$-64 Mil. It means Prince Pharmaceutical Co's inventory increased by NT$64 Mil from Dec. 2024 to Dec. 2025 .

Prince Pharmaceutical Co's Total Inventories for the quarter that ended in Jun. 2026 was NT$299 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Prince Pharmaceutical Co's Days Inventory for the quarter that ended in Jun. 2026 was 93.51.

Inventory Turnover measures how fast the company turns over its inventory within a year. Prince Pharmaceutical Co's Inventory Turnover for the quarter that ended in Jun. 2026 was 1.95.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Prince Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.41.

Prince Pharmaceutical Co  (ROCO:6935) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Prince Pharmaceutical Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=252.423/492.619*365 / 2
=93.51

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Prince Pharmaceutical Co's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=492.619 / 252.423
=1.95

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Prince Pharmaceutical Co's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=252.423 / 616.644
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prince Pharmaceutical Co Change In Inventory Related Terms

Prince Pharmaceutical Co Change In Inventory Historical Data

* Premium members only.

The historical data trend for Prince Pharmaceutical Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prince Pharmaceutical Co Change In Inventory Chart

Prince Pharmaceutical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial -32.09 -24.42 7.74 0.65 -64.09

Prince Pharmaceutical Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.79 -4.15 -31.50 -32.60 -93.72
ROCO:6935
62GF Score
Prince Pharmaceutical Co Ltd ROCO:6935
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prince Pharmaceutical Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-126 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of NT$-126 Mil mean?
Prince Pharmaceutical Co (ROCO:6935) has a Change In Inventory of NT$-126 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Prince Pharmaceutical Co and its competitors.
Is Prince Pharmaceutical Co's Change In Inventory too high?
Prince Pharmaceutical Co's current Change In Inventory is NT$-126 Mil. Overall, Prince Pharmaceutical Co has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Prince Pharmaceutical Co's Change In Inventory compare to ZTS?
Prince Pharmaceutical Co's Change In Inventory of NT$-126 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Prince Pharmaceutical Co and its competitors. Prince Pharmaceutical Co's current Change In Inventory is NT$-126 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prince Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Prince Pharmaceutical Co (ROCO:6935) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$42.29, compared to a current price of NT$27.10 — trading 35.9% below its estimated fair value. The current Change In Inventory is NT$-126 Mil. Prince Pharmaceutical Co's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Prince Pharmaceutical Co (ROCO:6935), the current Change In Inventory is NT$-126 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prince Pharmaceutical Co (ROCO:6935) Overvalued in 2026?

Based on GuruFocus' analysis, Prince Pharmaceutical Co stock appears to be undervalued. The current stock price of NT$27.10 is trading 35.9% below its estimated GF Value™ of NT$42.29. GuruFocus considers Prince Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for ROCO:6935:

  • Change In Inventory: NT$-126 Mil
  • GF Value™: NT$42.29 vs. price of NT$27.10 (35.9% below fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6935 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prince Pharmaceutical Co Business Description

Address Number 168, Keyunnan Road, Huwei Town, Yunlin, TWN, 632
Prince Pharmaceutical Co Ltd is engaged in the manufacturing, packaging, processing, and trading of various active pharmaceutical ingredients and health supplements. The company supplies its products to Taiwan, Japan, Spain, Europe and other regions.
62GF Score

Get the complete analysis for ROCO:6935

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$27.10
Price
NT$42.29
GF Value